Results for tag: "Skin Fibrosis Drug"

The Skin Fibrosis Drug market is a subset of the Dermatological Drugs market, which includes drugs used to treat skin conditions. Skin Fibrosis Drugs are used to treat a variety of skin conditions, including scleroderma, systemic sclerosis, and localized scleroderma. These drugs are typically administered orally or intravenously, and can be used to reduce inflammation, improve skin elasticity, and reduce scarring. Common side effects of Skin Fibrosis Drugs include nausea, vomiting, and diarrhea. The Skin Fibrosis Drug market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Novartis, Merck, and Johnson & Johnson. Other companies in the market include AbbVie, GlaxoSmithKline, and Sanofi. Show Less Read more